MSKCC is launching a clinical trial that uses a MEK inhibitor to target ETV1 in combination with imatinib on a small group of newly diagnosed GIST patients
Read MoreETV1 inhibitor takes lead in combination approach to clinical trials
Get Support Today - 973-837-9092
-
Attend an Upcoming GIST Day of Learning
Educate yourself about GIST and get involved in the GIST Community by attending GDOL!
-
The GIST Community Can Do Anything They Want!
GIST patients, caregivers, and supporters are living life to the fullest. Take charge of your GIST care today.
-
The Life Raft Group is Involved in Ground Breaking Research
The Life Raft Group Research Team is working tirelessly to find a cure for GIST.
-
Join the Life Raft Group Community
Being a part of the LRG Community means that you will never have to face GIST alone!
-
The Life Raft Group Continually Focuses on Advocacy
Alianza GIST is making great advocacy strides in Latin America. Sign our petition to ensure GISTers receive the safest treatments possible!
-
Norman Scherzer Discusses Founding The Life Raft Group
Executive Director Norman Scherzer talks about the founding of the Life Raft Group and the importance of Gleevec in the fight against GIST (Gastrointestinal Stromal Tumor).
Donate NowMake A Gift to the Life Raft Group Today - Every Amount Makes an Impact!
ARE YOU NEWLY DIAGNOSED?
The LRG is here to help, join our community of patients, caregivers and specialists!
Learn MoreARE YOU A SURVIVOR?
We have the latest in GIST news and research for you to take control of your treatment!
Learn MoreARE YOU A MEDICAL PROFESSIONAL?
We are accepting applications to be listed among our GIST Specialists.
Learn More
